日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial

辅助性阿特珠单抗治疗早期三阴性乳腺癌:ALEXANDRA/IMpassion030随机临床试验

Ignatiadis, Michail; Bailey, Andrew; McArthur, Heather; El-Abed, Sarra; de Azambuja, Evandro; Metzger, Otto; Chui, Stephen Y; Dieterich, Max; Perretti, Thomas; Shearer-Kang, Esther; Molinero, Luciana; Steger, Günther G; Jassem, Jacek; Lee, Soo Chin; Higgins, Michaela; Zarba, Jose; Schmidt, Marcus; Gomez, Henry; Guerrero Zotano, Angel; Moscetti, Luca; Chiu, Joanne; Munzone, Elisabetta; Ben-Baruch, Noa Efrat; Bajetta, Emilio; Ohno, Shinji; Im, Seock-Ah; Werutsky, Gustavo; Gal-Yam, Einav Nili; Gonzalez Farre, Xavier; Tseng, Ling-Ming; Jacot, William; Gluz, Oleg; Shao, Zhimin; Shparyk, Yaroslav; Zimina, Anastasia; Winer, Eric; Cameron, David A; Viale, Giuseppe; Saji, Shigehira; Gelber, Richard; Piccart, Martine

Genetic alterations affect immune contexture of non-small cell lung cancer: Ukrainian study

基因改变影响非小细胞肺癌的免疫结构:乌克兰研究

Kozakov, Denys; Kobyliak, Nazarii; Livshun, Sofiia; Seleznov, Oleksii; Koshyk, Olena; Matvieieva, Alina; Shparyk, Yaroslav; Kolesnik, Oleksii; Moskalenko, Yuliia; Vynnychenko, Oleksandr; Moskalenko, Roman; Kropyvko, Serhii; Khmel, Anna; Shkarupii, Bogdana; Sulaieva, Oksana

Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial

SB3曲妥珠单抗生物类似药治疗ERBB2阳性早期乳腺癌的心脏安全性和疗效:一项随机临床试验的二次分析

Pivot, Xavier; Cortés, Javier; Lüftner, Diana; Lyman, Gary H; Curigliano, Giuseppe; Bondarenko, Igor M; Ahn, Jin-Hee; Im, Seock-Ah; Litwiniuk, Maria; Shparyk, Yaroslav V; Ho, Gwo Fuang; Kislov, Nikolay V; Wojtukiewicz, Marek; Sarosiek, Tomasz; Chae, Yee Soo; Ahn, Jin Seok; Jang, Hyerin; Kim, Sujung; Lee, Jiwon; Yoon, YeChan

Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial

HLX02 与参考药物曲妥珠单抗在复发或转移性 HER2 阳性乳腺癌患者中的疗效、安全性和免疫原性比较:一项随机 III 期等效性试验

Xu, Binghe; Zhang, Qingyuan; Sun, Tao; Li, Wei; Teng, Yue'e; Hu, Xichun; Bondarenko, Igor; Adamchuk, Hryhoriy; Zhang, Liangming; Trukhin, Dmytro; Wang, Shusen; Zheng, Hong; Tong, Zhongsheng; Shparyk, Yaroslav; Wang, Qingyu

Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial

维利帕尼联合卡铂/紫杉醇治疗HER2阴性转移性或局部晚期乳腺癌患者的安全性和有效性:基于BRCA1/2种系突变和激素受体状态的3期BROCADE3试验亚组分析

Ayoub, Jean-Pierre; Wildiers, Hans; Friedlander, Michael; Arun, Banu K; Han, Hyo S; Puhalla, Shannon; Shparyk, Yaroslav; Jakobsen, Erik H; Wu, Meijing; Bach, Bruce A; Feng, Dai; Ratajczak, Christine K; Maag, David; Diéras, Véronique

Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia

一项随机3期疗效和安全性试验,评估拟上市的培非格司亭生物类似药MYL-1401H在预防化疗引起的嗜中性粒细胞减少症中的疗效和安全性。

Waller, Cornelius F; Ranganna, Gopinath M; Pennella, Eduardo J; Blakeley, Christopher; Bronchud, Miguel H; Mattano, Leonard A Jr; Berzoy, Oleksandr; Voitko, Nataliia; Shparyk, Yaroslav; Lytvyn, Iryna; Rusyn, Andriy; Popov, Vasil; Láng, István; Beckmann, Katrin; Sharma, Rajiv; Baczkowski, Mark; Kothekar, Mudgal; Barve, Abhijit

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

在BRCA1/2局部复发/转移性乳腺癌患者中,维利帕尼联合替莫唑胺或卡铂/紫杉醇与安慰剂联合卡铂/紫杉醇的疗效比较:一项随机II期研究

Han, H S; Diéras, V; Robson, M; Palácová, M; Marcom, P K; Jager, A; Bondarenko, I; Citrin, D; Campone, M; Telli, M L; Domchek, S M; Friedlander, M; Kaufman, B; Garber, J E; Shparyk, Y; Chmielowska, E; Jakobsen, E H; Kaklamani, V; Gradishar, W; Ratajczak, C K; Nickner, C; Qin, Q; Qian, J; Shepherd, S P; Isakoff, S J; Puhalla, S

Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial

帕博西尼联合来曲唑对患者自述健康相关生活质量的影响:PALOMA-2试验结果

Rugo, H S; Diéras, V; Gelmon, K A; Finn, R S; Slamon, D J; Martin, M; Neven, P; Shparyk, Y; Mori, A; Lu, D R; Bhattacharyya, H; Bartlett, C H U A N G; Iyer, S; Johnston, S; Ettl, J; Harbeck, N

A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel

一项针对接受多柔比星和多西他赛化疗的乳腺癌患者的巴鲁格司亭与培非格司亭的III期研究

Gladkov, Oleg; Moiseyenko, Vladimir; Bondarenko, Igor N; Shparyk, Yaroslav; Barash, Steve; Adar, Liat; Avisar, Noa